MHC-I INTRATUMOR HETEROGENEITY DETERMINES ONCOGENIC AND METASTATIC CAPACITY, AND IMMUNE RESPONSE

被引:0
|
作者
Romero-Garcia, Irene [1 ]
Linares, Isabel [1 ]
Algarra, Ignacio [2 ]
Collado, Antonia [3 ]
Garrido, Federico [1 ]
Garcia-Lora, Angel [1 ]
机构
[1] Hosp Univ Virgen de las Nieves, UGC Lab Clin, Granada, Spain
[2] Univ Jaen, Dept Ciencias Salud, Jaen, Spain
[3] Hosp Univ Virgen de las Nieves, Unidad Invest, Granada, Spain
来源
TISSUE ANTIGENS | 2014年 / 84卷 / 01期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [41] ENFORCED TUMOR SPECIFIC MHC-I HETEROGENEITY IN TRIPLE NEGATIVE BREAST CANCER DRIVES IMMUNOTHERAPY RESISTANCE
    Taylor, Brandie
    Balko, Justin
    Sanders, Melinda
    Gonzalez-Ericsson, Paula
    Sanchez, Violeta
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A342 - A342
  • [42] A Commentary on RIPK2: The Hidden Driver of MHC-I Related Immune Suppression in Cancer
    Yang, Qian
    Ruif, Alina Leonie
    Meder, Lydia
    BIOCELL, 2025, 49 (02) : 161 - 165
  • [43] Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
    Luo, Xiaobo
    Qiu, Yan
    Fitzsimonds, Zackary R.
    Wang, Qiuhao
    Chen, Qianming
    Lei, Yu Leo
    ONCOGENE, 2024, 43 (06) : 388 - 394
  • [44] MHC-I SURFACE EXPRESSION IN TUMOR CELLS MAY DETERMINE SUCCESS OF ANTI-METASTATIC IMMUNOTHERAPY
    Garrido, Cristina
    Romero, Irene
    Linares, Isabel
    Rodriguez, Ana
    Algarra, Ignacio
    Collado, Antonia
    Garrido, Federico
    Garcia-Lora, Angel
    TISSUE ANTIGENS, 2012, 79 (06): : 595 - 595
  • [45] Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells
    Xian, Jinhuan
    Gao, Leilei
    Ren, Zhenyang
    Jiang, Yanjun
    Pan, Junjun
    Ying, Zheng
    Guo, Zhenyuan
    Du, Qingsong
    Zhao, Xu
    Jin, He
    Yi, Hua
    Guan, Jieying
    Hu, Shan
    CELLS, 2024, 13 (18)
  • [46] Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort
    Sun, Xiaopeng
    Kennedy, Laura C.
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Sanders, Melinda
    Perou, Charles M.
    Troester, Melissa A.
    Balko, Justin M.
    Reid, Sonya A.
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 4077 - 4081
  • [47] microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients
    Mari, Luigi
    Hoefnagel, Sanne J. M.
    Zito, Domenico
    van de Meent, Marian
    van Endert, Peter
    Calpe, Silvia
    Serra, Maria del Carmen Sancho
    Heemskerk, Mirjam H. M.
    van Laarhoven, Hanneke W. M.
    Hulshof, Maarten C. C. M.
    Gisbertz, Susanne S.
    Medema, Jan Paul
    Henegouwen, Mark I. van Berge
    Meijer, Sybren L.
    Bergman, Jacques J. G. H. M.
    Milano, Francesca
    Krishnadath, Kausilia K.
    GASTROENTEROLOGY, 2018, 155 (03) : 784 - 798
  • [48] MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration
    Marconi, Giovanni
    Fontana, Maria Chiara
    Fonzi, Eugenio
    Papayannidis, Cristina
    Abbenante, Mariachiara
    Ottaviani, Emanuela
    Testoni, Nicoletta
    Simonetti, Giorgia
    Padella, Antonella
    Sartor, Chiara
    Baldazzi, Carmen
    Nanni, Jacopo
    Bertamini, Luca
    Di Rora, Andrea Ghelli Luserna
    Robustelli, Valentina
    Pazzaglia, Martina
    Tenti, Elena
    Parisi, Sarah
    Martinelli, Giovanni
    BLOOD, 2017, 130
  • [49] MHC CLASS-I AND NON-MHC-LINKED CAPACITY FOR GENERATING AN ANTIVIRAL CTL RESPONSE DETERMINES SUSCEPTIBILITY TO CTL EXHAUSTION AND ESTABLISHMENT OF VIRUS PERSISTENCE IN MICE
    MOSKOPHIDIS, D
    LECHNER, F
    HENGARTNER, H
    ZINKERNAGEL, RM
    JOURNAL OF IMMUNOLOGY, 1994, 152 (10): : 4976 - 4983
  • [50] CXCL1 promotes immune escape in colorectal cancer by autophagy-mediated MHC-I degradation
    Kong, Jianqiao
    Xu, Song
    Zhang, Peng
    Zhao, Yun
    HUMAN IMMUNOLOGY, 2023, 84 (12)